BTAI Stock Analysis: Buy, Sell, or Hold?
BTAI - BioXcel Therapeutics, Inc. Common Stock
$1.59
-0.03 (-1.85%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When BTAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called BTAI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BTAI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BTAI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BTAI is currently trading at $1.59, which is considered oversold relative to its 30-day fair value range of $1.64 to $1.95.
Technical Outlook: Technically, BTAI is in a strong downtrend. Immediate support is located at $1.52, while resistance sits at $2.08.
Market Sentiment: BTAI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.75 (+934.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BTAI is in a strong downtrend. Immediate support is located at $1.52, while resistance sits at $2.08.
Market Sentiment: BTAI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.75 (+934.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.64 -
$1.95
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding BTAI? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 934.0% below Wall St target ($16.75)
- CAUTION: 5-day price weakness (-12.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.64 -
$1.95
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.52
Resistance Level
$2.08
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.52
Wall Street Target
$16.75
(+934.0%)
Revenue Growth (YoY)
-54.2%
Last updated: January 31, 2026 9:40 AM ET
Data refreshes hourly during market hours. Next update: 10:40 AM
Data refreshes hourly during market hours. Next update: 10:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced BTAI Option Strategies
Professional options setups generated by AI based on today's BTAI price and gamma walls.
